Main Menu

ICR-CTSU Integrative Genomic Analysis in Clinical Trials

Dr Maggie Cheang’s multidisciplinary team within the ICR’s Clinical Trials and Statistics Unit of statistical, computational and translational scientists analyses large datasets generated from bio-specimens collected in clinical trials to study the underlying biology of tumours.

Group leader

Dr Maggie Cheang

Dr Maggie Cheang

Team Leader

Dr Maggie Cheang develops genomics classifiers for tumour subtypes and determines their clinical utility to predict sensitivity of each tumour type to therapeutic agents in phase II and III clinical trials. She co-invented the 50 genes-based classifier for the intrinsic subtypes of breast cancer, commonly known as PAM50 and currently licensed as Prosigna®.

ORCID 0000-0001-5718-2501

Group members

Dr Milana Bergamino

Honorary Appointment

Yingtong Chen

Biomedical Vacation Student

Monisha Dewan

Medical Statistician

Holly Tovey

Senior Statistician

Jasmin Waterhouse

MD Research Student

Freya Whittaker

Biomedical Vacation Student

Xixuan Zhu

PhD Student